Gene therapy in the treatment of peripheral arterial disease

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

(2011) Jill Belch et al.   LANCET

An integrative model for vascular endothelial growth factor A as a tumour biomarker

(2010) Antony M. Latham et al.   Integrative Biology

Results of a Double-Blind, Placebo-Controlled Study to Assess the Safety of Intramuscular Injection of Hepatocyte Growth Factor Plasmid to Improve Limb Perfusion in Patients With Critical Limb Ischemia

(2008) Richard J. Powell et al.   CIRCULATION

Fibroblast growth factor regulation of neovascularization

(2008) Masahiro Murakami et al.   CURRENT OPINION IN HEMATOLOGY

Gene therapy as a novel therapeutic option in the treatment of peripheral vascular disease: systematic review and meta-analysis

(2008) R. Ghosh et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia

(2008) Sigrid Nikol et al.   MOLECULAR THERAPY